{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:00Z","timestamp":1787019840501,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean Headache Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraine is a neurological, primary headache disorder affecting more than 1 billion people worldwide, with a multi-faceted burden that can significantly impact the everyday life of a patient, both during and between attacks. However, studies on patient awareness, burden, and clinical management of migraine in Korea are limited and outdated. The aim of this study was to comprehensively investigate the current difficulties and unmet needs that Korean patients with migraine encounter from their perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 207 patients with episodic or chronic migraine aged between 15 and 76\u2009years, completed a survey designed to cover the following topics: diagnosis, understanding of the disease, treatment experience, disability, and quality of life. Patients were recruited by their neurologists from 11 specialized headache clinics in Korea and completed the survey between 22 July and 19 August 2019. Validated scales such as the Migraine Disability Assessment (MIDAS) questionnaire and Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv2.1) were used to assess levels of disability and quality of life, respectively, in patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On average, it took 10.1\u2009years from onset of symptoms to diagnosis and a mean of 3.9 hospitals were visited for treatment prior to the patient\u2019s current hospital. There was a lack of understanding among respondents about migraine, with 55.6% believing that unilateral headache is a unique feature of migraine compared with other headache disorders. On average, high levels of disability and poor quality of life were reported by patients, as assessed by MIDAS and MSQv2.1, respectively, but only 23.7% had regularly taken preventive medication in the past. Overall satisfaction with previous doctor-patient relationships was reported by 29.5% of respondents, and satisfaction with preventive and acute medications by only 40.8% and 27.1% of the respondents, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Korean patients with migraine experience significant disability and reduced quality of life as a result of the disease and have clear unmet needs in terms of diagnosis, understanding of the disease, and disease management including treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-021-01250-6","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T09:02:56Z","timestamp":1621846976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Burden of migraine and unmet needs from the patients\u2019 perspective: a survey across 11 specialized headache clinics in Korea"],"prefix":"10.1186","volume":"22","author":[{"given":"Byung-Kun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Dell\u2019Agnello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-3763","authenticated-orcid":false,"given":"Soo-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"issue":"10","key":"1250_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(19)30281-9","volume":"18","author":"T Wijeratne","year":"2019","unstructured":"Wijeratne T, Grisold W, Dodick D, Carroll W (2019) World brain day 2019: migraine, the painful truth. Lancet Neurol 18(10):914. https:\/\/doi.org\/10.1016\/S1474-4422(19)30281-9","journal-title":"Lancet Neurol"},{"key":"1250_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"372","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel YW, Cowan RP (2017) Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 372:307\u2013315. https:\/\/doi.org\/10.1016\/j.jns.2016.11.071","journal-title":"J Neurol Sci"},{"issue":"10159","key":"1250_CR3","first-page":"1789","volume":"392","author":"GBD","year":"2017","unstructured":"GBD (2017) Disease and injury incidence and prevalence collaborators (2018) global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 392(10159):1789\u20131858","journal-title":"Lancet."},{"issue":"1","key":"1250_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19(1):17","journal-title":"J Headache Pain"},{"issue":"1","key":"1250_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1129-2377-15-31","volume":"15","author":"TJ Steiner","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M et al (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15(1):31. https:\/\/doi.org\/10.1186\/1129-2377-15-31","journal-title":"J Headache Pain"},{"issue":"1","key":"1250_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people's life. J Headache Pain 20(1):41. https:\/\/doi.org\/10.1186\/s10194-019-0993-0","journal-title":"J Headache Pain"},{"issue":"7","key":"1250_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/0333102414552532","volume":"35","author":"AM Adams","year":"2015","unstructured":"Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, Lipton RB (2015) The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Cephalalgia. 35(7):563\u2013578. https:\/\/doi.org\/10.1177\/0333102414552532","journal-title":"Cephalalgia."},{"issue":"8","key":"1250_CR8","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/head.12878","volume":"56","author":"RB Lipton","year":"2016","unstructured":"Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML (2016) A comparison of the chronic migraine epidemiology and outcomes (CaMEO) study and American Migraine Prevalence and Prevention (AMPP) study: demographics and headache-related disability. Headache. 56(8):1280\u20131289. https:\/\/doi.org\/10.1111\/head.12878","journal-title":"Headache."},{"issue":"8","key":"1250_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/head.13613","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, Lipton RB (2019) Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 59(8):1286\u20131299. https:\/\/doi.org\/10.1111\/head.13613","journal-title":"Headache."},{"issue":"1","key":"1250_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10194-016-0649-2","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Tassorelli C, Katsarava Z, Lainez JM, Lanteri-Minet M et al (2016) Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain 17(1):59. https:\/\/doi.org\/10.1186\/s10194-016-0649-2","journal-title":"J Headache Pain"},{"issue":"2","key":"1250_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/head.13470","volume":"59","author":"TJ Song","year":"2019","unstructured":"Song TJ, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK (2019) Sex differences in prevalence, symptoms, impact, and psychiatric comorbidities in migraine and probable migraine: a population-based study. Headache. 59(2):215\u2013223. https:\/\/doi.org\/10.1111\/head.13470","journal-title":"Headache."},{"key":"1250_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.12688\/f1000research.12447.1","volume":"7","author":"P-K Chen","year":"2018","unstructured":"Chen P-K, Wang S-J (2018) Non-headache symptoms in migraine patients. F1000Res 7:188","journal-title":"F1000Res"},{"key":"1250_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fneur.2010.00142","volume":"1","author":"S-J Wang","year":"2010","unstructured":"Wang S-J, Chen P-K, Fuh J-L (2010) Comorbidities of migraine. Front Neurol 1:16","journal-title":"Front Neurol"},{"issue":"9","key":"1250_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11916-017-0641-9","volume":"21","author":"CP Yang","year":"2017","unstructured":"Yang CP, Wang SJ (2017) Sleep in patients with chronic migraine. Curr Pain Headache Rep 21(9):39. https:\/\/doi.org\/10.1007\/s11916-017-0641-9","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1250_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16(1):76\u201387. https:\/\/doi.org\/10.1016\/S1474-4422(16)30293-9","journal-title":"Lancet Neurol"},{"issue":"4","key":"1250_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/head.12328","volume":"54","author":"KP Peng","year":"2014","unstructured":"Peng KP, Wang SJ (2014) Epidemiology of headache disorders in the Asia-pacific region. Headache. 54(4):610\u2013618. https:\/\/doi.org\/10.1111\/head.12328","journal-title":"Headache."},{"issue":"1","key":"1250_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1129-2377-14-82","volume":"14","author":"MK Chu","year":"2013","unstructured":"Chu MK, Kim DW, Kim BK, Kim JM, Jang TW, Park JW, Lee KS, Cho SJ (2013) Gender-specific influence of socioeconomic status on the prevalence of migraine and tension-type headache: the results from the Korean headache survey. J Headache Pain 14(1):82. https:\/\/doi.org\/10.1186\/1129-2377-14-82","journal-title":"J Headache Pain"},{"issue":"3","key":"1250_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3988\/jcn.2012.8.3.204","volume":"8","author":"BK Kim","year":"2012","unstructured":"Kim BK, Chu MK, Lee TG, Kim JM, Chung CS, Lee KS (2012) Prevalence and impact of migraine and tension-type headache in Korea. J Clin Neurol 8(3):204\u2013211. https:\/\/doi.org\/10.3988\/jcn.2012.8.3.204","journal-title":"J Clin Neurol"},{"issue":"13","key":"1250_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0333102413484990","volume":"33","author":"BK Kim","year":"2013","unstructured":"Kim BK, Chung YK, Kim JM, Lee KS, Chu MK (2013) Prevalence, clinical characteristics and disability of migraine and probable migraine: a nationwide population-based survey in Korea. Cephalalgia. 33(13):1106\u20131116. https:\/\/doi.org\/10.1177\/0333102413484990","journal-title":"Cephalalgia."},{"issue":"5","key":"1250_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1046\/j.1526-4610.1998.3805356.x","volume":"38","author":"JK Roh","year":"1998","unstructured":"Roh JK, Kim JS, Ahn YO (1998) Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache. 38(5):356\u2013365. https:\/\/doi.org\/10.1046\/j.1526-4610.1998.3805356.x","journal-title":"Headache."},{"issue":"1","key":"1250_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-018-0911-x","volume":"19","author":"YJ Choi","year":"2018","unstructured":"Choi YJ, Kim BK, Chung PW, Lee MJ, Park JW, Chu MK, Ahn JY, Kim BS, Song TJ, Sohn JH, Oh K, Lee KS, Kim SK, Park KY, Chung JM, Moon HS, Chung CS, Cho SJ (2018) Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study. J Headache Pain 19(1):78. https:\/\/doi.org\/10.1186\/s10194-018-0911-x","journal-title":"J Headache Pain"},{"issue":"1","key":"1250_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10194-019-1062-4","volume":"20","author":"T Takeshima","year":"2019","unstructured":"Takeshima T, Wan Q, Zhang Y, Komori M, Stretton S, Rajan N, Treuer T, Ueda K (2019) Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain 20(1):111. https:\/\/doi.org\/10.1186\/s10194-019-1062-4","journal-title":"J Headache Pain"},{"issue":"9","key":"1250_CR23","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1526-4610.2008.01088.x","volume":"48","author":"SJ Wang","year":"2008","unstructured":"Wang SJ, Chung CS, Chankrachang S, Ravishankar K, Merican JS, Salazar G, Siow C, Cheung RTF, Phanthumchinda K, Sakai F (2008) Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache. 48(9):1356\u20131365. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01088.x","journal-title":"Headache."},{"issue":"3","key":"1250_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3988\/jcn.2014.10.3.236","volume":"10","author":"JW Park","year":"2014","unstructured":"Park JW, Moon HS, Kim JM, Lee KS, Chu MK (2014) Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol 10(3):236\u2013243. https:\/\/doi.org\/10.3988\/jcn.2014.10.3.236","journal-title":"J Clin Neurol"},{"issue":"1","key":"1250_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-019-1012-1","volume":"20","author":"K Ueda","year":"2019","unstructured":"Ueda K, Ye W, Lombard L, Kuga A, Kim Y, Cotton S, Jackson J, Treuer T (2019) Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain 20(1):68. https:\/\/doi.org\/10.1186\/s10194-019-1012-1","journal-title":"J Headache Pain"},{"issue":"1","key":"1250_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1129-2377-14-47","volume":"14","author":"R Liu","year":"2013","unstructured":"Liu R, Yu S, He M, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, Steiner TJ (2013) Health-care utilization for primary headache disorders in China: a population-based door-to-door survey. J Headache Pain 14(1):47. https:\/\/doi.org\/10.1186\/1129-2377-14-47","journal-title":"J Headache Pain"},{"issue":"6 Suppl 1","key":"1250_CR27","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 56(6 Suppl 1):S20\u2013S28. https:\/\/doi.org\/10.1212\/WNL.56.suppl_1.S20","journal-title":"Neurology."},{"issue":"3","key":"1250_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1526-4610.2000.00030.x","volume":"40","author":"BC Martin","year":"2000","unstructured":"Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1). Headache. 40(3):204\u2013215. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.00030.x","journal-title":"Headache."},{"issue":"3","key":"1250_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1526-4610.2011.01997.x","volume":"52","author":"CL Bagley","year":"2012","unstructured":"Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, Kosinski M (2012) Validating migraine-specific quality of life questionnaire v2.1 in episodic and chronic migraine. Headache. 52(3):409\u2013421. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01997.x","journal-title":"Headache."},{"issue":"2","key":"1250_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1526-4610.2010.01778.x","volume":"51","author":"G Viticchi","year":"2011","unstructured":"Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, Provinciali L, Bartolini M (2011) Time delay from onset to diagnosis of migraine. Headache. 51(2):232\u2013236. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01778.x","journal-title":"Headache."},{"issue":"4","key":"1250_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.17340\/jkna.2015.4.6","volume":"33","author":"NJ Jo","year":"2015","unstructured":"Jo NJ, Kim BK (2015) Clinical characteristics of migraine with Aura in Korean: a clinic based study. J Korean Neurol Assoc 33(4):278\u2013281. https:\/\/doi.org\/10.17340\/jkna.2015.4.6","journal-title":"J Korean Neurol Assoc"},{"issue":"2","key":"1250_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-0030-1249221","volume":"30","author":"GC De Luca","year":"2010","unstructured":"De Luca GC, Bartleson JD (2010) When and how to investigate the patient with headache. Semin Neurol 30(2):131\u2013144. https:\/\/doi.org\/10.1055\/s-0030-1249221","journal-title":"Semin Neurol"},{"issue":"4","key":"1250_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0025-7125(05)70348-5","volume":"85","author":"RW Evans","year":"2001","unstructured":"Evans RW (2001) DIAGNOSTIC TESTING FOR HEADACHE. Med Clin N Am 85(4):865\u2013885. https:\/\/doi.org\/10.1016\/S0025-7125(05)70348-5","journal-title":"Med Clin N Am"},{"issue":"2","key":"1250_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3988\/jcn.2020.16.2.222","volume":"16","author":"BS Kim","year":"2020","unstructured":"Kim BS, Kim SK, Kim JM, Moon HS, Park KY, Park JW, Sohn JH, Song TJ, Chu MK, Cha MJ, Kim BK, Cho SJ (2020) Factors associated with incidental neuroimaging abnormalities in new primary headache patients. J Clin Neurol 16(2):222\u2013229. https:\/\/doi.org\/10.3988\/jcn.2020.16.2.222","journal-title":"J Clin Neurol"},{"issue":"1","key":"1250_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10072-011-0520-9","volume":"32","author":"G Viticchi","year":"2011","unstructured":"Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, Provinciali L, Bartolini M (2011) The role of instrumental examinations in delayed migraine diagnosis. Neurol Sci 32(1):143\u2013144. https:\/\/doi.org\/10.1007\/s10072-011-0520-9","journal-title":"Neurol Sci"},{"issue":"Suppl 2","key":"1250_CR36","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1017\/S0317167100001864","volume":"29","author":"RA Purdy","year":"2002","unstructured":"Purdy RA (2002) Migraine: the doctor-patient link. Results of a needs assessment. Can J Neurol Sci 29(Suppl 2):S3\u2013S7","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"1250_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11916-008-0040-3","volume":"12","author":"DC Buse","year":"2008","unstructured":"Buse DC, Lipton RB (2008) Facilitating communication with patients for improved migraine outcomes. Curr Pain Headache Rep 12(3):230\u2013236. https:\/\/doi.org\/10.1007\/s11916-008-0040-3","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"1250_CR38","doi-asserted-by":"publisher","first-page":"e017851","DOI":"10.1136\/bmjopen-2017-017851","volume":"7","author":"D Palacios-Cena","year":"2017","unstructured":"Palacios-Cena D, Neira-Martin B, Silva-Hernandez L, Mayo-Canalejo D, Florencio LL, Fernandez-de-Las-Penas C et al (2017) Living with chronic migraine: a qualitative study on female patients' perspectives from a specialised headache clinic in Spain. BMJ Open 7(8):e017851. https:\/\/doi.org\/10.1136\/bmjopen-2017-017851","journal-title":"BMJ Open"},{"issue":"5","key":"1250_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, Group AA (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 68(5):343\u2013349","journal-title":"Neurology."},{"issue":"5","key":"1250_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB (2016) Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 56(5):821\u2013834. https:\/\/doi.org\/10.1111\/head.12774","journal-title":"Headache."},{"issue":"1","key":"1250_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ (2018) Poor medical care for people with migraine in Europe - evidence from the Eurolight study. J Headache Pain 19(1):10. https:\/\/doi.org\/10.1186\/s10194-018-0839-1","journal-title":"J Headache Pain"},{"issue":"8","key":"1250_CR42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/head.12154","volume":"53","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Buse DC, Serrano D, Holland S, Reed ML (2013) Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache. 53(8):1300\u20131311. https:\/\/doi.org\/10.1111\/head.12154","journal-title":"Headache."},{"issue":"10","key":"1250_CR43","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1526-4610.2005.00259.x","volume":"45","author":"F Nachit-Ouinekh","year":"2005","unstructured":"Nachit-Ouinekh F, Dartigues JF, Chrysostome V, Henry P, Sourgen C, El Hasnaoui A (2005) Evolution of migraine after a 10-year follow-up. Headache. 45(10):1280\u20131287. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.00259.x","journal-title":"Headache."},{"issue":"4","key":"1250_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1046\/j.1468-2982.1997.1704488.x","volume":"17","author":"B Bille","year":"1997","unstructured":"Bille B (1997) A 40-year follow-up of school children with migraine. Cephalalgia. 17(4):488\u2013491; discussion 7. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1704488.x","journal-title":"Cephalalgia."},{"issue":"4","key":"1250_CR45","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/head.12055","volume":"53","author":"AM Blumenfeld","year":"2013","unstructured":"Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, Wilcox TK, Kawata AK, Lipton RB (2013) Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 53(4):644\u2013655. https:\/\/doi.org\/10.1111\/head.12055","journal-title":"Headache."},{"issue":"Suppl 1","key":"1250_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000085036","volume":"53","author":"M Lanteri-Minet","year":"2005","unstructured":"Lanteri-Minet M (2005) What do patients want from their acute migraine therapy? Eur Neurol 53(Suppl 1):3\u20139. https:\/\/doi.org\/10.1159\/000085036","journal-title":"Eur Neurol"},{"issue":"Suppl 1","key":"1250_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","volume":"42","author":"RB Lipton","year":"2002","unstructured":"Lipton RB, Hamelsky SW, Dayno JM (2002) What do patients with migraine want from acute migraine treatment? Headache. 42(Suppl 1):3\u20139. https:\/\/doi.org\/10.1046\/j.1526-4610.2002.0420s1003.x","journal-title":"Headache."},{"issue":"5","key":"1250_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1526-4610.2006.00437.x","volume":"46","author":"SN Malik","year":"2006","unstructured":"Malik SN, Hopkins M, Young WB, Silberstein SD (2006) Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 46(5):773\u2013780. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00437.x","journal-title":"Headache."}],"updated-by":[{"DOI":"10.1186\/s10194-021-01270-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01250-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01250-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T19:11:44Z","timestamp":1627672304000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01250-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01250-6","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-021-01270-2","URL":"https:\/\/doi.org\/10.1186\/s10194-021-01270-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants were recruited by their neurologists. Conducting of surveys is subject to Institutional Review Board exemption in Korea, but approval is required for preparation of a publication. Prior to participation, patients provided written consent to use the results of the survey for statistical purposes. Approval for preparation of this manuscript was granted by the Institutional Review Board of Nowon Eulji Medical Center (Approval No 2020\u201306-009). Survey data were handled confidentially, and anonymity of respondents was maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BKK has received consulting fees and honoraria from the Center for New Health Technology Assessment, National Pension Service, Eli Lilly, Allergan, Teva, Lundbeck, Novartis, Sanofi Korea, SK Pharm, Yuyu Pharm, and Ildong Pharm during the last two years. MKC was involved as a site investigator for a multicenter trial sponsored by Otsuka Korea, Allergan, Ildong Pharmaceutical Co., LTD, Novartis International AG, and Eli Lilly and Company. He has worked as an advisory member for Teva, and has received lecture honoraria from Allergan Korea, Handok-Teva and Yuyu Pharmaceutical Company. SJY is a full-time employee of Eli Lilly and Company. GDA is a full-time employee and a minor stockholder of Eli Lilly and Company. JHH is a full-time employee of Eli Lilly and Company. SJC was involved as a site investigator for a multicenter trial sponsored by Otsuka Korea, Allergan, Ildong Pharmaceutical Co., LTD, Novartis International AG, Eli Lilly and Company, Parexel Korea Co., Ltd., and has received lecture honoraria from Allergan Korea, WhanIn Pharm Co., LTD, Handok-Teva, Yuyu Pharmaceutical Company, and SK Chemicals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}